The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(5-(3-(4-Ethylpiperazin-l-yl)propyl)-2,3,4,5-tetrahydro-1H-benzo[b](1,4)diazepine-1-carbonyl)phenyl)(1,1'-biphenyl)-2-carboxamide ID: ALA5208751
PubChem CID: 168294720
Max Phase: Preclinical
Molecular Formula: C38H43N5O2
Molecular Weight: 601.80
Associated Items:
Names and Identifiers Canonical SMILES: CCN1CCN(CCCN2CCCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc32)CC1
Standard InChI: InChI=1S/C38H43N5O2/c1-2-40-26-28-41(29-27-40)22-10-23-42-24-11-25-43(36-17-9-8-16-35(36)42)38(45)31-18-20-32(21-19-31)39-37(44)34-15-7-6-14-33(34)30-12-4-3-5-13-30/h3-9,12-21H,2,10-11,22-29H2,1H3,(H,39,44)
Standard InChI Key: GGOOYOFDSPJDBT-UHFFFAOYSA-N
Molfile:
RDKit 2D
45 50 0 0 0 0 0 0 0 0999 V2000
-3.8232 0.1693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8232 -0.6556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1087 -1.0681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3942 -0.6556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7492 -1.1700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9327 -1.9743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7211 -2.2175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3280 -2.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5116 -3.3398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9068 -3.9009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1185 -3.6578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4862 -4.2189 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2745 -3.9757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4581 -3.1714 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8793 -4.5368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6957 -5.3411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3005 -5.9023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0889 -5.6591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2725 -4.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6677 -4.2937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8513 -3.4893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6396 -3.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8232 -2.4419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2184 -1.8807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4301 -2.1239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2465 -2.9282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0650 -2.8534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5396 -2.2923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9448 -0.9864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5869 -0.2431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9448 0.5001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7492 0.6837 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9327 1.4880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3280 2.0491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5115 2.8534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9068 3.4146 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1185 3.1714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4862 3.7326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3026 4.5369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9074 5.0980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7238 5.9023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4856 4.7800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0904 4.2189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3942 0.1693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1087 0.5818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
6 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
13 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 15 2 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 21 2 0
11 27 2 0
27 28 1 0
28 8 2 0
5 29 1 0
30 29 1 0
31 30 1 0
32 31 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
38 39 1 0
39 40 1 0
40 41 1 0
39 42 1 0
43 36 1 0
42 43 1 0
44 32 1 0
4 44 2 0
44 45 1 0
45 1 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 601.80Molecular Weight (Monoisotopic): 601.3417AlogP: 6.49#Rotatable Bonds: 9Polar Surface Area: 59.13Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 8.31CX LogP: 5.95CX LogD: 4.99Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.24Np Likeness Score: -1.33
References 1. Cao X, Wang P, Yuan H, Zhang H, He Y, Fu K, Fang Q, Liu H, Su L, Yin L, Xu P, Xie Y, Xiong X, Wang J, Zhu X, Guo D.. (2022) Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease., 65 (13.0): [PMID:35579344 ] [10.1021/acs.jmedchem.2c00567 ]